A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Clinical trial NCT01400555 · COMPLETED
Trial details
- NCT number
- NCT01400555
- Sponsor
- Cougar Biotechnology, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2011-09-01
- Primary completion
- 2014-05-12
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.